Qinqin Cheng

Title(s)Postdoctoral Scholar - Research Associate
Phone+1 323 442 3383
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Shi X, Cheng Q, Zhang Y. Reprogramming Extracellular Vesicles with Engineered Proteins. Methods. 2019 Sep 27. PMID: 31568822.
      View in: PubMed
    2. Zhang XN, Cheng Q, Chen J, Lam AT, Lu Y, Dai Z, Pei H, Evdokimov NM, Louie SG, Zhang Y. A ribose-functionalized NAD+ with unexpected high activity and selectivity for protein poly-ADP-ribosylation. Nat Commun. 2019 Sep 13; 10(1):4196. PMID: 31519936.
      View in: PubMed
    3. Zhang XN, Dai Z, Cheng Q, Zhang Y. Chemoenzymatic Preparation of 4'-Thioribose NAD. Curr Protoc Nucleic Acid Chem. 2019 Jun; 77(1):e83. PMID: 30951610.
      View in: PubMed
    4. Cheng Q, Shi X, Han M, Smbatyan G, Lenz HJ, Zhang Y. Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity. J Am Chem Soc. 2018 Dec 05; 140(48):16413-16417. PMID: 30452238.
      View in: PubMed
    5. Dai Z, Zhang XN, Nasertorabi F, Cheng Q, Pei H, Louie SG, Stevens RC, Zhang Y. Facile chemoenzymatic synthesis of a novel stable mimic of NAD. Chem Sci. 2018 Nov 28; 9(44):8337-8342. PMID: 30568770.
      View in: PubMed
    6. Zhu P, Atkinson C, Dixit S, Cheng Q, Tran D, Patel K, Jiang YL, Esckilsen S, Miller K, Bazzle G, Allen P, Moore A, Broome AM, Nadig SN. Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo. RSC Adv. 2018 Jul 23; 8(46):25909-25919. PMID: 30220998.
      View in: PubMed